Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_assertion type Assertion NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_head.
- NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_assertion description "[mGluR1 inhibitors (Riluzole or BAY36-7620) inhibited the proliferation of triple negative breast cancer cells in a time- and dose-dependent manner and this inhibition correlated with increased apoptosis as demonstrated by increase in PARP cleavage products and Annexin V staining.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_provenance.
- NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_assertion evidence source_evidence_literature NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_provenance.
- NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_assertion SIO_000772 21681448 NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_provenance.
- NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_assertion wasDerivedFrom befree-20150227 NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_provenance.
- NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_assertion wasGeneratedBy ECO_0000203 NP435536.RA8eyVdmvd88Heerd4tBGdsrgL5ymNHtqisb2b8vrn_G4130_provenance.